Company Shine-On BioMedical Co.,Ltd.

Equities

6926

TW0006926009

Biotechnology & Medical Research

End-of-day quote Taipei Exchange 18:00:00 2024-06-25 EDT 5-day change 1st Jan Change
66.5 TWD -0.15% Intraday chart for Shine-On BioMedical Co.,Ltd. +1.99% -4.18%

Business Summary

Shine-On BioMedical Co Ltd is a Taiwan-based company mainly engaged in the research, development and manufacture of anti-cancer related new drug products. Antibody products include trispecific T cell engaging nanobody (SOA101), EphA10 trispecific antibody engaging immune cells (SOA201), iNb Intrabody nanoscale intracellular specific antibody drug (SOA102), iNb STAR TriTE T cell receptor Nano-scale trispecific antibody drug (SOA103). Nucleic acid drugs include exosome-carrying nucleic acid and chemotherapy drugs (SOB101).

Number of employees: 19

Sales per Business

TWD in Million2022Weight2023Weight Delta
Anti-cancer Related Drug Products
100.0 %
0 nan % 10 100.0 % -

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
100.0 %
0 nan % 10 100.0 % -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 49,800,000 40,412,700 ( 81.15 %) 0 81.15 %

Company contact information

Shine-On BioMedical Co., Ltd.

5/F-6 633 Section 2, Taiwan Boulevard

407569, Taichung

+

http://www.shineon-bio.com
address Shine-On BioMedical Co.,Ltd.(6926)
  1. Stock Market
  2. Equities
  3. 6926 Stock
  4. Company Shine-On BioMedical Co.,Ltd.